Aavant Research
Finnrick has tested 12 samples from Aavant Research across 2 products.
Finnrick Vendor Profile
Aavant Research
Tracking 2 products
12 total samples tested
Last test 11 Feb 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Retatrutide | 6 | 11 Aug 2025 | 11 Feb 2026 | |||||
| Tirzepatide | 6 | 24 Oct 2025 | 7 Jan 2026 | |||||
Most recent Aavant Research tests
Samples are tested in commercial labs
12
tests
2
products
Scores
AVGMINMAX
First
11 Aug 2025
Last
11 Feb 2026
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 11 Feb 2026 | Retatrutide | View | 12mg | (no batch claim) | 13.4mg | +11.7% | 99.90% | 967286-000004 | Silver Label / Silver Crimp / Black Cap | Lab E | Public | |
| 7 Jan 2026 | Retatrutide | View | 11mg | (no batch claim) | 10.9mg | -0.9% | 99.70% | 967286-000003 | Silver Label / Silver Crimp / Black Cap | Lab G | Public | |
| 7 Jan 2026 | Tirzepatide | View | 29.93mg | (no batch claim) | 31.4mg | +4.9% | 99.80% | 967284-000009 | Silver Label / Black Crimp / Pink Cap | Lab G | Public | |
| 7 Jan 2026 | Tirzepatide | View | 60mg | (no batch claim) | 61.6mg | +2.7% | 99.80% | 967288-000002 | Silver Label / Teal Crimp / Clear Pink Cap | Lab G | Public | |
| 18 Nov 2025 | Tirzepatide | View | 25mg | (no batch claim) | 24.6mg | -1.6% | 99.77% | 967284-000008 | White Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 17 Nov 2025 | Tirzepatide | View | 25mg | 28.0mg | 25.9mg | -7.6% | 99.94% | 967284-000008 | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 30 Oct 2025 | Tirzepatide | View | 50mg | 53.2mg | 57.02mg | +7.1% | 99.80% | 967288-000001 | White Label / Green Crimp / Clear Pink Cap | Lab G | Public | |